Hanwha Life Launches 'Newspecial Cancer Insurance' Covering Prevention, Diagnosis, and Treatment of Cancer

Hanwha Life launched the 'Hanwha Life Newspecial Cancer Insurance,' which covers everything from cancer prevention to diagnosis and treatment, on the 9th.

[Asia Economy Reporter Oh Hyung-gil] Hanwha Life Insurance launched the 'Hanwha Life Newspecial Cancer Insurance,' which covers everything from cancer prevention to diagnosis and treatment, on the 9th.

Two new cancer prevention riders have been introduced to prevent precursor diseases from progressing to cancer. The 'Surgery Rider for Benign Neoplasms of 12 Major Organs (including polyps of 3 major organs)' and the 'Treatment Coverage Rider for Hyperthyroidism' provide coverage for surgery and treatment costs related to cancer precursor diseases.

Additionally, the product's features for cancer diagnosis coverage have been enhanced. A non-renewable type has been introduced, allowing customers who are concerned about premium increases to choose stable coverage by opting for the non-renewable plan instead of the renewable one.

In particular, cancer riders have been prepared for each body part such as the respiratory system, liver, pancreas, stomach, and esophagus, enabling customers to receive additional coverage for the cancers they desire.

Furthermore, coverage related to cancer treatment has been strengthened. By subscribing to the newly established Targeted Anticancer Drug Approval Treatment Rider, coverage of up to 50 million KRW (limited to the first time) is provided for targeted anticancer drug approval treatment for cancer, other skin cancers, and thyroid cancer. In addition, the coverage amount for the anticancer drug and radiation treatment rider has increased from the previous 500,000 KRW to a maximum of 2 million KRW.

Sung Yoon-ho, head of product development at Hanwha Life, said, "The Special Cancer Insurance, which has received much love, has returned in a more advanced form. By breaking away from the fixed notion that cancer insurance only covers diagnosis funds and significantly expanding the coverage range from prevention to treatment, customers will be able to thoroughly prepare for cancer."

This content was produced with the assistance of AI translation services.